ELV Elevance Health : Bullish and Bearish Analyst Opinions

Under my plan, I want to stop all payments to big insurance companies and instead give the money directly to the people so that they can buy their own healthcare. Managed care organizations derive a massive portion of their revenue and earnings from government-sponsored programs, including ACA subsidies, Medicare, and Medicaid. Cutting off direct federal payments to these insurers would severely compress their margins, disrupt their revenue base, and force a complete restructuring of the health insurance market. SHORT. The administration is actively targeting the profitability and government funding mechanisms of major managed care companies. Congress blocks the proposed healthcare overhaul, maintaining the status quo for managed care revenues and government subsidies.

Bought 3,000 shares @ $289.84

Trump attacks the Affordable Care Act, stating he wants to "stop all payments to big insurance companies" and notes that "insurance companies own Democrats." He also touts "Most Favored Nation" clauses dropping drug prices by 80%. The removal of federal subsidies/payments is a direct hit to the revenue of managed care organizations (UnitedHealth, Humana). Simultaneously, aggressive price controls on drugs compress margins for the broader healthcare/pharma sector. SHORT Managed Care and Big Pharma. Congressional gridlock preventing the removal of subsidies.

The administration is pushing a healthcare framework that looks to "shift federal subsidies from the insurance companies to consumers." Managed Care Organizations (MCOs) rely heavily on federal subsidies (Medicare Advantage, etc.) for margin. Direct-to-consumer subsidies bypass the insurers, potentially squeezing their margins and reducing their role as intermediaries. SHORT large cap insurers heavily exposed to government programs. The healthcare lobby is powerful and may water down or block the transfer of subsidy mechanics.

Schneider explicitly highlights the "extension of the premium tax subsidies" as a priority, warning that without it, "millions of families are seeing their insurance increase by $1,500 a month." These subsidies (enhanced ACA tax credits) are direct revenue drivers for Managed Care Organizations (MCOs) focused on the exchange market. Schneider's push indicates that Democrats will make extending these credits a non-negotiable condition in budget talks. If extended, enrollment numbers for Centene, Molina, and others remain robust; if they lapse, churn increases and revenue drops. LONG. The political pressure to avoid an $18k/year cost spike for voters is high, favoring an eventual extension which benefits ACA-heavy insurers. Republican opposition to "pandemic-era" subsidy extensions could lead to a lapse, crushing margins for exchange-focused insurers.

The President intends to "codify his health care framework that seeks to shift federal subsidies from health care companies to U.S. consumers." Managed Care Organizations (MCOs) and insurers rely heavily on government subsidies (particularly in Medicare Advantage). Shifting these funds directly to consumers bypasses the insurers, threatening their margins and revenue models. SHORT. This represents a structural change to healthcare funding flows detrimental to intermediaries. The complexity of healthcare reform often leads to watered-down implementation.

"I want to stop all payments to big insurance companies and instead give that money directly to the people... stock prices soared... like nothing else." The administration views the "middleman" model of Managed Care Organizations (MCOs) as the primary driver of healthcare inflation. Shifting federal subsidies (ACA/Medicare) directly to patients bypasses the insurers, threatening their revenue streams and margin compression. SHORT. The political target on the back of the insurance sector is now explicit policy. The lobby for healthcare insurers is powerful; implementation of direct payments may face logistical gridlock.

Under the "No Surprises Act," insurers are losing over 80% of arbitration cases to providers regarding out-of-network bills. This creates a structural headwind for margins as insurers are forced to pay higher rates than anticipated. Additionally, the State of the Union address is expected to target insurer profitability and affordability, adding headline risk. WATCH / AVOID. Regulatory relief or changes to the arbitration process could alleviate cost pressures.

The administration proposed a "0.09% next year" payment increase. Holz notes investors were "positioning long thinking this was going to be a turnaround year," but now we are entering a "pocket now for a year, maybe two, in which earnings don't expand or grow." The macro environment for government-sponsored healthcare has shifted from a growth story to a stagnation story. While the stocks have dropped 20%, the fundamental driver for stock price appreciation (earnings growth) has been removed for the medium term. Buying the dip is premature because the capital will be tied up in a sector with no catalyst for 12-24 months. Do not buy the dip yet. The thesis has shifted from "turnaround" to "stagnation." The final ruling in April could be revised upward significantly, causing a relief rally (short squeeze).